His scientific interests lie mostly in Psychiatry, Heroin, Addiction, Methadone and Drug. His research integrates issues of Injury prevention, MEDLINE and Public health in his study of Psychiatry. His Heroin research is multidisciplinary, relying on both Opioid overdose, Harm reduction, Randomized controlled trial and Substance abuse.
His Addiction research is multidisciplinary, incorporating perspectives in Naloxone, Medical emergency, Detoxification and Emergency medicine. His Methadone study integrates concerns from other disciplines, such as Buprenorphine and Medical prescription. His studies deal with areas such as Ecstasy, Stimulant, Route of administration and Risk factor as well as Drug.
John Strang mostly deals with Psychiatry, Heroin, Addiction, Methadone and Drug. Psychiatry and Public health are commonly linked in his work. His research in Heroin intersects with topics in Opioid overdose, Naloxone and Emergency medicine.
The Naloxone study combines topics in areas such as Drug overdose and Medical emergency. His biological study spans a wide range of topics, including Buprenorphine, Medical prescription, Family medicine and Detoxification. His Psychological intervention research includes themes of Intervention and Randomized controlled trial.
John Strang spends much of his time researching Psychiatry, Opioid overdose, Heroin, Naloxone and Psychological intervention. His study on Addiction and Mental health is often connected to Context as part of broader study in Psychiatry. He combines subjects such as Harm reduction, Anesthesia, Opioid antagonist and Respiratory system with his study of Opioid overdose.
John Strang has researched Heroin in several fields, including Methadone, Opioid use disorder, Emergency medicine, Buprenorphine and Qualitative research. His work in Naloxone covers topics such as Injury prevention which are related to areas like Fentanyl, Interim and Occupational safety and health. The concepts of his Psychological intervention study are interwoven with issues in Intervention, Randomized controlled trial, Cognitive therapy, Public health and Craving.
His primary scientific interests are in Opioid overdose, Psychiatry, Naloxone, Heroin and Methadone. His Alcohol abuse study in the realm of Psychiatry connects with subjects such as Screening tool. His studies in Naloxone integrate themes in fields like Pharmacokinetics, Anesthesia, Bioavailability, Injury prevention and Nasal administration.
His work carried out in the field of Heroin brings together such families of science as Qualitative research, Medication adherence and Emergency medicine. His work deals with themes such as Buprenorphine, Risk of mortality and Cause of death, which intersect with Methadone. His study on Harm reduction also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.
Michael Gossop;Shane Darke;Paul Griffiths;Julie Hando.
The Maudsley Addiction Profile (MAP):A brief instrument for assessing treatment outcome.
John Marsden;Michael Gossop;Duncan Stewart;David Best.
Understanding reasons for drug use amongst young people: a functional perspective
Annabel Boys;John Marsden;John Strang.
Health Education Research (2001)
The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial.
Jim McCambridge;John Strang.
Drug Policy and the Public Good
Thomas F. Babor;Jonathan P. Caulkins;Griffith Edwards;Benedikt Fischer.
Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review
M Farrell;J Ward;R Mattick;W Hall.
Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues
Peter Griffiths;Michael Gossop;B Powis;John Strang.
Severity of dependence and route of administration of heroin, cocaine and amphetamines
Michael Gossop;Paul Griffiths;Beverly Powis;John Strang.
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database
Rosie Cornish;John Macleod;John Strang;Peter Vickerman;Peter Vickerman.
Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria.
Rebecca McDonald;John Strang.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: